General Atlantic, Aquitaine, Avesi, PPC Enterprises target speech therapy; Stable pharmaceutical demand leads SK Capital-backed Apotex to C$1.3bn IPO
Early intervention is leading to more diagnoses in children of conditions that require speech therapy, fueling demand in the segment and catching the eye of private equity; discussing the largest life sciences IPO in the Toronto Stock Exchange’s history, launched by SK Capital-backed Apotex.
12 June 2026•4 mins read
